Abstract Code: IUC24430-78 Lesion-Level Meta-Diagnostic of Cognitive vs Fusion MRI-Targeted Biopsy in PCa: PRECISION-2 InsightsR. Daniswara 1, M. Amin 1, R. Zaidan 1 (1)...
IUC24430-78
read more
Abstracts 2025
IUC24426-83
Abstract Code: IUC24426-83 Predictors of Cancer Detection on Local Anaesthetic Transperineal (LATP) Prostate Biopsy: A Single-Centre AnalysisM. Ali 1, M. Thomas 1, M. Sanan 1, J....
IUC24425-82
Abstract Code: IUC24425-82 Nanosensors for early stage detection of Circulating Tumour Cell biomarkers in Prostate Cancer Diagnosis: A Systematic Review of Published Evidence S....
IUC24404-79
Abstract Code: IUC24404-79 Ultrasound Use via SAU for Testicular Pain Lasting Over 24 Hours: An Audit of Clinical Utility U. Daniyal 1, J. Peace 1, V. Patel 2 (1) London North...
IUC24380-82
Abstract Code: IUC24380-82 Prophylactic Antibiotics Use in Local Anaesthetic Transperineal Ultrasound Guided Prostate Biopsy: A Retrospective Observational StudyK. Rhodes 1, V....
IUC23534-82
Abstract Code: IUC23534-82 Incidental Detection of Renal Masses Following Implementation of Abdominal Imaging in Prostate mpMRI ProtocolF.R. Antara 1, M. Hussain 2, S. Tadtayev...
IUC23530-78
Abstract Code: IUC23530-78 Diagnostic Value, Safety, and Patient-Reported Outcomes of Total Free-Hand LATP Biopsy TechniqueA. Elftheriadou 1, F.R. Antara 1, C. Collins 1, D....
IUC22936-87
Abstract Code: IUC22936-87 Evaluating Negative Biopsy Outcomes for Suspicious Bladder Red Patches – Are We Over-performing Biopsy? A Two-Cycle Audit. A. Hossain 1, P. Papikinos...
IUC24413-79
Abstract Code: IUC24413-79 Comparative Performance of AI vs Radiologists in Pre-Biopsy mpMRI Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis of Multi-Centre,...
IUC23424-80
Abstract Code: IUC23424-80 Comparative Analysis of Wallace Versus Bricker Anastomosis in Radical Cystectomy: A Prospective Study of 50 PatientsO.V. Potdar 1 (1) MUMBAI - India...
IUC24427-84
Abstract Code: IUC24427-84 Reducing UTI and Sepsis After Flexible Cystoscopy: Impact of a Protocol-Based Approach in High-Risk Patients – Outcomes from a high-volume university...
IUC24432-80
Abstract Code: IUC24432-80 Neoadjuvant or Induction Chemotherapy (N/IC) for Bladder Cancer: Updated “Real-World” Experience from CroatiaJ. Murgic 1, M. Jazvic 1, I. Tomaskovic 2,...
IUC24424-81
Abstract Code: IUC24424-81 Real-world Efficacy and Safety of maintenance Avelumab in Locally Advanced or Metastatic Urothelial Cancer O. Okuma 1, O. Olatunji 1, E.C. Okuofo 1 (1)...
IUC24412-78
Abstract Code: IUC24409-84 Evaluation of a Transurethral Laser Ablation (TULA) Service for Superficial Bladder Cancer Management in an Outpatient Setting in a UK District General...
IUC24409-84
Abstract Code: IUC24409-84 Evaluation of a Transurethral Laser Ablation (TULA) Service for Superficial Bladder Cancer Management in an Outpatient Setting in a UK District General...
IUC24408-83
Abstract Code: IUC24408-83 Outcomes of Distal ureterectomy with Boari flap reconstruction for ureteric Transitional cell carcinoma.R. Abdlbagi 1, S. Ahmed 1, H. Nour 1, A....
IUC24403-78
Abstract Code: IUC24403-78 Relative Dose Intensity of Neoadjuvant Chemotherapy Predicts Pathological Response and Survival in Muscle-Invasive Urothelial Cancer: A Multicenter...
IUC24400-75
Abstract Code: IUC24400-75 Real-World Outcomes of Second-Line Pembrolizumab in Urothelial Cancer: Campania Network AnalysisR. Tambaro 1, E. Perri 2, A. Muto 3, L. Formisano 4, G....
IUC24396-89
Abstract Code: IUC24396-89 The fate of the hydronephrotic kidney in muscle-invasive bladder cancer.M. Gami 1, T. Rich 1, H. Motiwala 1 (1) Southend University Hospital, Essex,...
IUC24392-85
Abstract Code: IUC24392-85 Real-world use of erdafitinib in urothelial carcinoma: an Italian multicenter retrospective studyA. Dri 1, A. Polymeropoulos 2, E. Lai 3, F. Pierantoni...
IUC23438-85
Abstract Code: IUC23438-85 Clinico-pathological profile of Bladder cancer patients in a Tertiary care Centre. O.V. Potdar 1 (1) MUMBAI - India Introduction: Bladder cancer (BC)...
IUC24434-82
Abstract Code: IUC24434-82 Real-World Use of Abiraterone and Olaparib in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Two-Centre UK ExperienceM. Ali Hassan 1, J....
IUC24433-81
Abstract Code: IUC24433-81 Docetaxel versus olaparib plus abiraterone as first-line treatment in patients with mCRPC: a retrospective single-centre analysisM. Maffezzoli 1, L....
IUC24421-78
Abstract Code: IUC24421-78 Treatment Timing and Chronobiological Aspects of ADT Resistance in Real-World mCRPC Patients!. Bivolarski 1 (1) Burgas - Bulgaria Background:...
IUC24406-81
Abstract Code: IUC24406-81 ARTA-ATTACK Study: Assessment of Sarcopenia, Frailty, and Neurocognitive Impairment in Patients with Prostate Cancer Treated with Androgen...
IUC24405-80
Abstract Code: IUC24405-80 Retrospective study of Apalutamide/Enzalutamide in Hormone Sensitive Metastatic Prostate Cancer. S. Okinbaloye 1, G. Olukiran 2, S. Ramamurthy 2, A....
IUC24402-77
Abstract Code: IUC24402-77 Preliminary results of 177Lu-PSMA-617 priming with Enzalutamide in Metastatic Castration-resistant Prostate Cancer: A Single-arm Phase 2 trial...
IUC24398-91
Abstract Code: IUC24398-91 Functional and oncological outcomes of robot‐assisted radical prostatectomy in obese men: a matched‐pair analysis D.D. Carbin Joseph 1, S. Dranova 1,...
IUC24397-90
Abstract Code: IUC24397-90 Short-term continence outcomes in men over 75 undergoing robotic-assisted radical prostatectomy D. Papanikolaou 1, D. Carbin 1, S. Dranova 1, D....
IUC24025-78
Abstract Code: IUC24025-78 Early results of moderate hypofractionated radiotherapy implementation for localized prostate cancer patients in Vietnam. C. Nguyen Dinh 1, K. Nguyen...
IUC23262-80
Abstract Code: IUC23262-80 Comparison of clinical outcome and toxicity of prostate cancer patients undergoing radical prostate radiotherapy using spacer gel versus prostate...
IUC23223-77
Abstract Code: IUC23223-77 Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer in Asian patients A. Zakirov 1, F. Djuraev 1, O. Raxmonov 1, A. Jumaev 1 (1) Tashkent...
IUC23442-80
Abstract Code: IUC23442-80 Role of Renal Nephrometry score in predicting peri-operative outcomes following partial nephrectomy. O.V. Potdar 1 (1) MUMBAI - India ...
IUC24428-85
Abstract Code: IUC24428-85 Real World Effectiveness of Ipilimumab plus Nivolumab in Second-Line in Patients with Metastatic Clear Cell Renal Cell Carcinoma (mccRCC) Based on...
IUC24419-85
Abstract Code: IUC24419-85 Real-life experience with metastatic renal cell carcinoma treated with combination of Cabozantinib and Nivolumab: A single-center retrospective...
IUC23448-86
Abstract Code: IUC23448-86 An interesting case of a mucinous cystadenoma of a horseshoe kidney in a middle-aged woman. O.V. Potdar 1 (1) MUMBAI - India A 48-year-old female...
IUC24414-80
Abstract Code: IUC24414-80 Optimizing Sunitinib Therapy in mRCC Through Pharmacological Counselling and Early TDM Integration G. Bortolus 1, E. Cecchin 2, S. Gagno 2, B. Posocco...
IUC24394-87
Abstract Code: IUC24394-87 Meet-URO score update in Metastatic Renal Cell Carcinoma receiving 1st line Immune-Combinations Pasquale Rescigno1, Aruni Ghose2, Nicholas Brown3,...
IUC24360-80
Abstract Code: IUC24360-80 Second-line therapies of Metastatic Renal Cell Carcinoma (mRCC) after 1st line immune-combinations (ICI-combos) (Meet-URO 33 study) D. Bimbatti 1, C....
IUC24358-87
Abstract Code: IUC24358-87 Prognostic assessment of the Meet-URO score compared with the IMDC score in Metastatic Renal Cell Carcinoma (mRCC) receiving 1st line systemic...
IUC22940-82
Abstract Code: IUC22940-82 A 7-Year Review of Robot-Assisted vs Laparoscopic Radical Nephrectomy at a UK District General Hospital (2018–2024)A. Hossain 1, S. Khan 1, A....
IUC24415-81
Abstract Code: IUC24415-81 Clinical outcomes in stage I seminoma patients aged ≥ 45 years according to treatment modalityF. Mascaro 1, A. Marmiroli 2, A. Nuzzo 2, M. Maruzzo 3,...
IUC24429-86
Abstract Code: IUC24429-86 Real-World Use of Bone-Modifying Agents (BMA) in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the USZ.I. Ozay 1, Y. Jo 1,...
IUC24422-79
Abstract Code: IUC24422-79 Patient Satisfaction with Penile Prosthesis Insertion following Radical Pelvic Uro-Oncological Therapy J. Hay 1, S. Michael 1, E. Maher 2, A. Haider...
IUC22370-79
Abstract Code: IUC22370-79 Sleep Disturbances in Androgen Deprivation Therapy (ADT)-Treated Patients: A Narrative ReviewF. Rajaee Rizi 1 (1) Department of Urology, Al-Zahra...
IUC24431-79
Abstract Code: IUC24431-79 Prognostic Role of Luminal and Basal Subtypes in Metastatic Prostate Cancer: A Retrospective StudyS. Merler 1, A. Sordo 2, M. Brunelli 3, F. Zacchi...
IUC24420-77
Abstract Code: IUC24420-77 Prognostic impact of ABCA1/ABCG1 expression, lipid parameters, and nephrectomy in patients with renal cell carcinoma receiving immune checkpoint...
IUC24418-84
Abstract Code: IUC24418-84 Biomarkers detecting Minimal Residual Disease for predicting Risk of Relapse in Operable Urothelial Cancer: A Systematic Review and Meta-Analysis of...
IUC24417-83
Abstract Code: IUC24417-83 Correlation of Circulating Tumour DNA with Oncological Endpoints in Metastatic Urothelial Cancer: A Systematic Review and Meta-Analysis of Phase...
IUC24411-77
Abstract Code: IUC24411-77 In Search of Metastasis-Initiating Cells in Prostate CancerJulia Richert¹, Robert Wenta¹, Anna Muchlińska¹, Beata Pieczyńska-Uziębło¹, Anna Żaczek1,...
IUC24410-76
Abstract Code: IUC24410-76 Early PSA suppression with adjuvant abiraterone in high-risk prostate cancer: real-world data on the achievement of ultralow PSA levelsF. Di Costanzo...
IUC24390-83
Abstract Code: IUC24390-83 Morphology of Circulating Tumor Cells: how it might relate to biology and clinics in prostate cancerR. Wenta 1, J. Richert 1, A. Muchlinska 1, B....
IUC22021-72
Abstract Code: IUC22021-72 The INSIDE Study: Innovative Preclinical Models for Precision Medicine in Advanced Prostate CancerA. Opattova 1, L. Bizzozero 1, S.E. Bellomo 1, L....